Non-Toxic Disinfectant Reported to Kill Bubonic Plague Bacteria

Article

ALPINE, Utah -- American Biotech Labs recently completed a series of tests at a level three laboratory using its newly approved medical disinfectant ASAP-AGX-32. The product was tested against a concentration of 81,000,000 Y. pestis bacteria per milliliter. It killed all of them in less than two minutes.

Y. pestis is a bacterium that causes Bubonic Plague, also known as the black death. It killed one third of the population of Europe in the 14th century, and even today can kill 60 percent of untreated victims in three to five days. While there have been sporadic outbreaks in the United States, a more serious concern is the potential for weaponized Plague.

Said Keith Moeller, vice president of American Biotech Labs, "The ASAP-AGX-32 product has already been approved by the Environmental Protection Agency (EPA) for use against gram negative bacteria and Y. pestis is a gram negative bacterium. We wanted to test the limits of the product's capability, and we are delighted with the results. A normal in vitro (test tube) bacterial test uses a load of 500,000 bacteria per milliliter. The level of plague causing bacteria in our sample was 160 times that normal amount. The ASAP-AGX-32 disinfectant killed the bacteria in less than two minutes."

The ASAP-AGX-32 (EPA registration No. 73499-2) is unique in that it has no color or odor. Unlike other disinfectants, the ASAP ASAP-AGX-32 can be used or sprayed around both adults and children with no toxic effect. The product is not known to irritate the skin, eyes, nose, or lungs. To date, this product has killed every strain of every bacterium on which it has been tested. It has received EPA approval for use against the most deadly bacteria, including gram negative, gram positive and even nosocomial or hospital acquired (superbug) pathogens. The product has been approved for use as a broad spectrum, general use surface disinfectant in homes, hospitals, and medical settings.

Source: Clifton Mining Company

Recent Videos
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Physicians Sound Alarm: Vaccine Misinformation and Policy Failures Threaten US Public Health
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Related Content